BioPharma
India, Switzerland Discuss Pharma and Biotech Collaboration
Piyush Goyal, the Commerce and Industry Minister, met Helene Budliger Artieda, the visiting Swiss State Secretary for Economic Affairs, and discussed cooperation when it comes to research and development as well as pharma and biotech collaboration with a view...
News
Iraq To Open Largest Cancer Drug Factory in The Region
Iraq looks forward to inaugurating the region’s largest cancer drug factory in Abu Ghraib, which is situated 32 kilometers – equivalent to 20 miles west of Baghdad, in December 2025 at a cost of around 50 million euros.
This step...
BioPharma
Algeria Showcases its Strength in African Pharma Sector
Abdelmadjid Tebboune, the Algerian president, went on to address participants at the African Ministerial Conference on Local Pharmaceutical Production and Health Technologies on November 27, 2025, with his message being read by Sifi Ghrieb, the prime minister.
The event, which...
News
The Future of Health and Wellbeing: A Market on the Rise
The health and wellbeing market has experienced significant growth over the past decade, driven by an increasing awareness of physical and mental health issues. As we look to the future, projections suggest that this trend will continue, with the...
News
Synthetic Drugs: A Growing Crisis or Signs of Improvement?
The landscape of drug usage has undergone significant changes in recent years, particularly with the rise of synthetic drugs. These substances, often engineered to mimic the effects of traditional illicit drugs, have raised alarm bells among health officials and...
BioPharma
Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation
Eli Lilly, the US pharma giant, has become the first drugmaker to hit $1tn valuation on November 22, 2025, hence entering the exclusive club, which is so far dominated by technology giants, highlighting its rise as a weight-loss powerhouse.
The...
Business & Industry
400 Global Regulatory Manufacturing Approvals for Samsung Biologics
Samsung Biologics announced on November 26, 2025, that it has gone on to achieve a whopping 400 regulatory manufacturing approvals all over the world due to its quality competitiveness.
It is worth noting that as of November 2025, Samsung Biologics has secured...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.